Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
Crossref DOI link: https://doi.org/10.1007/s40119-016-0069-z
Published Online: 2016-08-18
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kalra, Sanjay
Funding for this research was provided by:
This paper was financially supported by AstraZeneca Pharma India Ltd, Bangalore, India.
